hypocalcaemia
Check albumin-adjusted or ionised Ca²⁺, Mg²⁺, PO₄³⁻, and PTH. Low/inappropriately normal PTH → hypoparathyroidism or hypomagnesaemia; high PTH → vitamin D deficiency, CKD, pancreatitis, PO₄³⁻ load, or potent antiresorptives. Symptomatic or adjusted Ca²⁺ <1.9 mmol/L (2022 Workshop: <1.75) → IV calcium gluconate bolus then infusion; chronic hypoparathyroidism → oral calcium + active vitamin D (calcitriol/alfacalcidol).
Symptomatic hypocalcaemia (tetany, carpopedal spasm, seizures, laryngospasm, prolonged QTc / torsades) at any level below normal → IV calcium gluconate immediately with ECG monitoring. Commonest acute in-hospital cause: total thyroidectomy or post-parathyroidectomy hungry bone syndrome.
causes by PTH
| PTH | causes |
|---|---|
| low or inappropriately normal | post-surgical (total thyroidectomy, parathyroidectomy — commonest; permanent if >12 months), hypomagnesaemia (impairs PTH secretion and causes PTH resistance; PPIs common) or severe hypermagnesaemia → phosphate and magnesium disorders, autoimmune (APS-1: AIRE mutation — mucocutaneous candidiasis, adrenal insufficiency, hypoparathyroidism), infiltrative (haemochromatosis, Wilson, metastases), DiGeorge (22q11.2) |
| high | vitamin D deficiency (↓ Ca, ↓ PO₄), CKD (↓ Ca, ↑ PO₄ → ckd complications), hungry bone syndrome (↓ Ca, ↓ PO₄, ↓ Mg within 1–4 days post-parathyroidectomy for severe 2°/3° HPT), pancreatitis, rhabdomyolysis / [[tumour lysis syndrome |
- Post-thyroidectomy prediction (Second Workshop 2022): a PTH >1.05 pmol/L (>10 pg/mL) at 12–24 hours post-total thyroidectomy virtually excludes permanent hypoparathyroidism (strong recommendation).
- Genetic testing: offer in non-surgical hypoparathyroidism if age <40, family history, or syndromic features.
acute management
Draw adjusted Ca²⁺ (or ionised Ca²⁺ when albumin/pH are abnormal), PO₄³⁻, Mg²⁺, PTH, creatinine, and 25-OH vitamin D. Symptoms usually emerge below ~1.9 mmol/L, depending on the rate of fall.
- Severe (symptomatic, or adjusted Ca²⁺ <1.9 mmol/L):
- Calcium gluconate 10%: 10–20 mL (2.2–4.4 mmol / 90–180 mg elemental Ca) in 50–100 mL D5W IV over 10–20 min with ECG monitoring; repeat until asymptomatic.
- Maintenance infusion: 100 mL calcium gluconate 10% (10 ampoules = 900 mg elemental Ca) in 1 L NS or D5W at 50–100 mL/h, titrated to keep Ca²⁺ in low-normal range until oral therapy takes hold.
- Calcium chloride: tissue irritant → central line only; dose by mmol (2.2–4.4 mmol load, then 1.1–2.2 mmol/h). Continuous ECG if on digoxin or arrhythmic. Avoid large-volume calcium infusions in ESKD/dialysis.
- Do not infuse calcium through the same IV line as phosphate or bicarbonate (precipitation) .
- Mild (asymptomatic, adjusted Ca²⁺ >1.9 mmol/L):
- Oral calcium 1–3 g elemental calcium/day in divided doses (calcium carbonate with meals; calcium citrate if on PPI or post-gastrectomy/bariatric surgery).
- Post-thyroidectomy: recheck Ca²⁺ at 24 h; if still low beyond 72 h (or 12–24 h PTH <1.05 pmol/L), start calcitriol 0.25–0.5 µg BID (or alfacalcidol) + oral calcium 2–3 g elemental/day.
cause-specific and chronic management
- Hypomagnesaemia: calcium will not correct until Mg²⁺ is repleted — stop culprit drug (PPI, diuretic) and give IV MgSO₄ (e.g. 24 mmol / 6 g in 500 mL over 24 h → phosphate and magnesium disorders).
- Vitamin D deficiency: cholecalciferol loading (~300,000 IU total over 6–10 weeks) + maintenance.
- Chronic hypoparathyroidism (Second Workshop 2022):
- Confirm with hypocalcaemia + undetectable/low/inappropriately normal PTH on 2 occasions ≥2 weeks apart (permanent if >12 months post-surgery).
- First-line (conventional therapy): oral calcium + active vitamin D (calcitriol 0.25–3 µg/day divided or alfacalcidol 0.5–6 µg/day — native vitamin D alone fails without PTH-driven 1α-hydroxylation).
- Target: low-normal serum Ca²⁺ (sufficient to relieve symptoms without causing hypercalciuria, nephrolithiasis/nephrocalcinosis, or CKD — screen baseline renal imaging; add a thiazide diuretic if hypercalciuric).
- Recombinant PTH (rhPTH / palopegteriparatide): consider if conventional therapy fails to control Ca²⁺, requires very high doses (Ca >2 g/day or calcitriol >2 µg/day), or causes renal complications.
- Pregnancy/lactation: monitor adjusted/ionised Ca²⁺ every 3–4 weeks (more often around delivery); avoid thiazides and PTH analogues.
- Hungry bone syndrome (post-parathyroidectomy for severe 2°/3° HPT): prolonged, severe hypocalcaemia + hypophosphataemia + hypomagnesaemia → often requires ICU IV calcium infusions, high-dose oral calcium + calcitriol, and Mg²⁺/PO₄³⁻ replacement.
- Denosumab in advanced CKD / dialysis (eGFR <30): carries a high risk of severe, protracted hypocalcaemia (ES 2023) — verify normal Ca²⁺, replete 25-OH vitamin D, and arrange close post-dose calcium monitoring before administering.
Prepared 2026-11-19. Not yet verified — check every number against the sources.